Minimal Change Disease Associated With Durvalumab
Kidney Int Rep
.
2021 Sep 1;6(10):2733-2734.
doi: 10.1016/j.ekir.2021.08.021.
eCollection 2021 Oct.
Authors
Masataro G Toda
1
,
Kentaro Fujii
1
,
Ai Kato
1
,
Ayumi Yoshifuji
1
,
Motoaki Komatsu
1
,
Yoshiaki Amino
2
,
Satoru Kitazono
2
,
Akinori Hashiguchi
3
,
Munekazu Ryuzaki
1
Affiliations
1
Division of Nephrology, Department of Internal Medicine, Tokyo Saiseikai Central Hospital, Tokyo, Japan.
2
Department of Respiratory Medicine, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
3
Department of Pathology, Keio University School of Medicine, Tokyo, Japan.
PMID:
34622115
PMCID:
PMC8484110
DOI:
10.1016/j.ekir.2021.08.021
No abstract available